{"nct_id":"NCT03929666","title":"A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer","status":"COMPLETED","status_verified_date":"2025-09","start_date":"2019-08-29","start_date_type":"ACTUAL","primary_completion_date":"2025-08-30","primary_completion_date_type":"ACTUAL","completion_date":"2025-08-30","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["JAZZ"]}